Sales decline 16.25% to Rs 65.52 crore
Net Loss of Venus Remedies reported to Rs 5.56 crore in the quarter ended June 2018 as against net loss of Rs 3.04 crore during the previous quarter ended June 2017. Sales declined 16.25% to Rs 65.52 crore in the quarter ended June 2018 as against Rs 78.23 crore during the previous quarter ended June 2017. ParticularsQuarter EndedJun. 2018Jun. 2017% Var.Sales65.5278.23 -16 OPM %15.4819.24 -PBDT2.647.13 -63 PBT-5.56-3.04 -83 NP-5.56-3.04 -83Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
